IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q3 2022 Holdings

Filed 2022-11-14 | 11 holdings | $267.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biora Inc.Note 7.250% 12/074319FAB3$62.8K$103,500,00023.5%
Amryt Pharma PLCSponsored ADS03217L106$61.3K8,857,26823.0%
Caremax IncCOM CL A14171W103$31.7K4,467,21911.9%
RVL Pharmaceuticals PLCSHSG6S41R101$30.7K14,600,44411.5%
Omeros CorpNOTE 5.250% 2/1682143AG7$22.3K$40,150,0008.4%
Omeros CorpNOTE 6.250%11/1682143AE2$19.2K$21,005,0007.2%
Biora Inc.COM74319F107$14.5K29,855,8475.4%
BridgeBio Pharma Inc.NOTE 2.250% 2/010806XAD4$8.7K$20,000,0003.3%
Paratek Pharmaceuticals Inc.NOTE 4.750% 5/0699374AB0$8.0K$9,000,0003.0%
Puma Biotechnology Inc(PBYI)COM74587V107$4.2K1,792,1141.6%
Societal Cdmo Inc.Com75629F109$3.6K2,202,4201.3%